We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+4.63%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$921M
AUM Growth
-$85.5M
Cap. Flow
-$110M
Cap. Flow %
-11.98%
Top 10 Hldgs %
14.09%
Holding
5,143
New
1,384
Increased
1,284
Reduced
1,171
Closed
1,233

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$11.2M
2
XOM icon
ExxonMobil
XOM
+$10.8M
3
AAPL icon
Apple
AAPL
+$10.8M
4
IBB icon
iShares Biotechnology ETF
IBB
+$10.2M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$8.12M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$265M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$98.3M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$32.7M
4
VNQ icon
Vanguard Real Estate ETF
VNQ
+$18.2M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$14.9M

Sector Composition

Rank Sector Weight
1 Financials 13.75%
2 Technology 8.29%
3 Industrials 7.33%
4 Healthcare 6.94%
5 Consumer Discretionary 6.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CHGG icon
1426
Chegg
CHGG
$98.4M
$50K 0.01%
6,744
+4,699
+230% +$35K
CLB icon
1427
Core Laboratories
CLB
$513M
$50K 0.01%
420
-115
-21% -$12.7K
CZNC icon
1428
Citizens & Northern Corp
CZNC
$453M
$50K 0.01%
+1,898
New +$44.6K
DEO icon
1429
Diageo
DEO
$51.6B
$50K 0.01%
478
-699
-59% -$73.5K
FIZZ icon
1430
National Beverage
FIZZ
$2.99B
$50K 0.01%
1,966
+1,546
+368% +$37.9K
TRN icon
1431
Trinity Industries
TRN
$2.47B
$50K 0.01%
2,495
-12,380
-83% -$228K
TXMD icon
1432
TherapeuticsMD
TXMD
$24.2M
$50K 0.01%
173
+157
+981% +$48.7K
ALR
1433
DELISTED
AlerisLife Inc
ALR
$50K 0.01%
1,860
-1,194
-39% -$31.7K
STBZ
1434
DELISTED
State Bank Financial Corporation. Common Stock
STBZ
$50K 0.01%
+1,895
New +$46.2K
PRXL
1435
DELISTED
Parexel International Corp
PRXL
$50K 0.01%
755
-360
-32% -$22.6K
AMBA icon
1436
Ambarella
AMBA
$3.68B
$49K 0.01%
905
-437
-33% -$26.4K
CVSA
1437
Covista Inc
CVSA
$4.23B
$49K 0.01%
1,590
-4,040
-72% -$109K
BCE icon
1438
BCE
BCE
$21.2B
$49K 0.01%
1,134
-1,559
-58% -$68.8K
BCO icon
1439
Brink's
BCO
$4.65B
$49K 0.01%
+1,199
New +$48.1K
FICO icon
1440
Fair Isaac
FICO
$22.3B
$49K 0.01%
412
-297
-42% -$35.3K
HAS icon
1441
Hasbro
HAS
$12.9B
$49K 0.01%
+627
New +$51.8K
MITK icon
1442
Mitek Systems
MITK
$759M
$49K 0.01%
+7,965
New +$52K
MMS icon
1443
Maximus
MMS
$3.06B
$49K 0.01%
881
-277
-24% -$15K
NHC icon
1444
National Healthcare
NHC
$3.43B
$49K 0.01%
+639
New +$44.3K
PFX icon
1445
PhenixFIN
PFX
$88.1M
$49K 0.01%
326
+184
+130% +$28.1K
SAIC icon
1446
Saic
SAIC
$5.25B
$49K 0.01%
580
-842
-59% -$64.6K
TLK icon
1447
Telkom Indonesia
TLK
$14.8B
$49K 0.01%
1,673
+333
+25% +$10.1K
UNFI icon
1448
United Natural Foods
UNFI
$2.9B
$49K 0.01%
1,016
+109
+12% +$4.89K
USFD icon
1449
US Foods
USFD
$23.6B
$49K 0.01%
+1,818
New +$43.6K
ZUMZ icon
1450
Zumiez
ZUMZ
$332M
$49K 0.01%
+2,253
New +$52.2K
56 57
58
59 60

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
GAMH
Greenwoods Asset Management (HK) Hong Kong $3.88B AUM 23.82% 1-Year Est. Return
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Tower Research Capital (TRC)'s Q4 2016 Portfolio in Review

As of Q4 2016, Tower Research Capital (TRC) held 5,143 positions worth $921M, down 8.5% from $1.01B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Tower Research Capital (TRC) withdrew a net $110M in Q4 2016, closing 1,233 positions and reducing 1,171 holdings. Its most notable exit was Vanguard Real Estate ETF, an estimated $18.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 3.3% a quarter earlier, followed by Technology and Industrials.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Biotechnology ETF worth $9.93M.

  • Tower Research Capital (TRC)'s largest Q4 2016 buy was iShares Biotechnology ETF: 112,296 shares worth $9.93M.
  • Tower Research Capital (TRC) added most to Microsoft in Q4 2016, an estimated $11.2M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $265M.
  • Tower Research Capital (TRC) fully exited Vanguard Real Estate ETF in Q4 2016, selling an estimated $18.2M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 14% of its $921M portfolio in Q4 2016.
  • Tower Research Capital (TRC) opened 1,384 new positions and closed 1,233 in Q4 2016.
  • Tower Research Capital (TRC)'s portfolio value fell 8.5% quarter-over-quarter to $921M.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2016, filed 3 Feb 2017.